Investor Relations

Press Releases

 
Press Releases
  Date Title View
May 1, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 1, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Deutsche Bank 40th Annual Health Care Conferenc...
Apr 28, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, 2015. "Our total revenues increased as compared to the prior year and we are continuing to see a growing number of patients being prescr...
Apr 21, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2015 financial results before market open on Tuesday, April 28, 2015. United Therapeutics will host a half-hour teleconference on Tuesday, April 28, 2015, at...
Mar 10, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA), as part of the Biologics License Application approval for Unituxin, awarded United Therapeutics a Rare Pediatric Priority Review Voucher (PPRV) ...
Mar 10, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 10, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the United States Food and Drug Administration (FDA) has approved Unituxin™ (dinutuximab) Injection (formerly called ch14.18), in combination with granulocyte-macrophage colony-stimulating fac...
Feb 25, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 35th Annual Healthcare...
Feb 24, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2014. "Our overall revenues and profits grew significantly from 2013 to 2014, and we are pleased to see continued growth in ...
Feb 17, 2015
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2014 financial results before market open on Tuesday, February 24, 2015. United Therapeutics will host a half-hour teleconference on Tuesday, Febr...
Jan 6, 2015
SILVER SPRING, Md., Jan. 6, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive Officer, and Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of United Therapeutics will provide an overview and update on the company's business at the 33rd Ann...
Dec 31, 2014
SILVER SPRING, Md., Dec. 31, 2014 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today the signing of an agreement with DEKA Research & Development Corp. for the development of a potential technology breakthrough in the subcutaneous delivery of Remodulin® (treprostinil) Injection to patients with pulmonary arterial hy...
1
... NextLast
= add release to Briefcase